Andere Kunden interessierten sich auch für
![Approach to the genetic study of epithelial ovarian cancer]( "Approach to the genetic study of epithelial ovarian cancer")
Approach to the genetic study of epithelial ovarian cancer30,99 €![HEREDITARY PREDISPOSITION TO BREAST AND/OR OVARIAN CANCER]( "HEREDITARY PREDISPOSITION TO BREAST AND/OR OVARIAN CANCER")
HEREDITARY PREDISPOSITION TO BREAST AND/OR OVARIAN CANCER40,99 €![Approche de l'étude génétique du cancer épithélial de l'ovaire]( "Approche de l'étude génétique du cancer épithélial de l'ovaire")
Approche de l'étude génétique du cancer épithélial de l'ovaire38,99 €![Abordagem do estudo genético do cancro epitelial do ovário]( "Abordagem do estudo genético do cancro epitelial do ovário")
Abordagem do estudo genético do cancro epitelial do ovário38,99 €![Approccio allo studio genetico del carcinoma ovarico epiteliale]( "Approccio allo studio genetico del carcinoma ovarico epiteliale")
Approccio allo studio genetico del carcinoma ovarico epiteliale38,99 €![Ansatz für die genetische Untersuchung von epithelialem Eierstockkrebs]( "Ansatz für die genetische Untersuchung von epithelialem Eierstockkrebs")
Ansatz für die genetische Untersuchung von epithelialem Eierstockkrebs59,90 €![Abordaje del estudio genético del cáncer de ovario epitelial]( "Abordaje del estudio genético del cáncer de ovario epitelial")
Abordaje del estudio genético del cáncer de ovario epitelial38,99 €
Results and discussion of our genetic study of epithelial ovarian cancer. Ovarian cancer is the gynaecological cancer with the highest mortality rate, with high-grade serous ovarian cancer accounting for 75% of this pathology, characterised by its aggressive course and diagnosis in advanced stages. One of the inclusion criteria according to the Spanish Society of Medical Oncology for high-risk hereditary breast and ovarian cancer syndrome (HOCCOS) is the diagnosis of non-mucinous high-grade epithelial ovarian cancer. HOCCOS has an autosomal dominant inheritance pattern in cancer susceptibility genes. Historically, the risk of SCMOH has been mainly linked to germline mutations in BRCA1/2. However, it is now also associated with tumour suppressor genes involved in DNA repair. High-grade ovarian cancer is evidenced by being genetically unstable and approximately 50% of these tumours are deficient in DNA repair mechanisms through homologous recombination.